Importance of model organisms in understanding the biology and genetic basis of human nonsyndromic neural tube defects

Teratology

Volumn 64, Issue 4, 2001, Pages 177-180

  Waes, Janée Gelineau Van ^a   Finnell, Richard H ^b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANENCEPHALUS; EDITORIAL; ENVIRONMENTAL FACTOR; EXENCEPHALY; GENE MUTATION; HEREDITY; HUMAN; NEURAL TUBE DEFECT; PRIORITY JOURNAL; RECURRENCE RISK; SPINA BIFIDA;

ANIMALS; DISEASE MODELS, ANIMAL; DNA; HUMANS; MICE; MICE, MUTANT STRAINS; MICE, TRANSGENIC; MUTATION; NEURAL TUBE DEFECTS;

EID: 0034807472     PISSN: 00403709     EISSN: None     Source Type: Journal    
DOI: 10.1002/tera.1062     Document Type: Editorial

References (17)

1. Lack of association between mutations in the folate receptor-alpha gene and spina bifida
2. 5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: A huge review
3. Neural tube defects: A review of human and animal studies on the etiology of neural tube defects
4. Racial variations in incidence of congenital malformations
5. Invited editorial: Why are the genes that cause risk of human neural tube defects so hard to find?
6. Etiologic heterogeneity of neural tube defects
7. Mouse models for neural tube closure defects
8. Delivery of folates to the cytoplasm of MA104 cells is mediated by a surface membrane receptor that recycles
9. Expression of the human folate receptor transcript is regulated in human tissues
10. Mice lacking the folic acid-binding protein Folbp1 are defective in early embryonic development
11. Structural and functional analysis of the human KB cell folate receptor gene P4 promoter: Cooperation of three clustered Sp1-binding sites with initiator region for basal promoter activity
12. Maternal vitamin use, genetic variation of infant methylenetetrahydrofolate reductase, and risk for spina bifida
13. Periconceptional vitamin use, dietary folate, and the occurrence of neural tube defects
14. Epidemiologic characteristics of phenotypically distinct neural tube defects among 0.7 million California births, 1983-1987
15. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida
16. Distribution of the folate receptor (gp 38) in normal and malignant cell lines and tissues